Our Company

About Us

YS Biopharma is a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA® immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Hepatitis B, Shingles, influenza, Coronavirus. YS Biopharma operates in China, Singapore, the United States, the United Arab Emirates and the Philippines with over 800 employees and led by a management team that combines rich local expertise and global vision in the vaccine and pharmaceutical industry.


Director, President and Chief Executive Officer

Chief Medical Officer

Director, Chief Financial Officer

Head of vaccine research

Head of marketing and sales

Board of Directors

David (Hui) Shao

Director, President and Chief Executive Officer

Ajit Shetty
(PhD, MBA)

Chairperson of the Board of Directors of the Company

Viren Mehta
(PharmD, MBA)

Independent Director

Rachel Yu

Independent Director

Yuntao Cui

Independent Director

Pierson Yue Pan


Chunyuan (Brenda) Wu

Director, Chief Financial Officer

Jin Wang

Independent Director

Henry Chen


Haitao Zhao


Scientific Advisor

Yunde Hou

(MD, PhD)

Yongxin Yu

Mann Fung


Guang Gao